Figure 2.

RT‐PCR A, and immunostaining. B, C, analysis of ERα and ERβ expression in prolactinomas from bromocriptine‐sensitive and ‐resistant patients. (Student's t test, ns, non‐significant, *P < 0.05)

RT‐PCR A, and immunostaining. B, C, analysis of ERα and ERβ expression in prolactinomas from bromocriptine‐sensitive and ‐resistant patients. (Student's t test, ns, non‐significant, *P < 0.05)